Publications by authors named "Maria Rodriguez-Remirez"

Claim this Profile
T
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.
Ander Puyalto, María Rodríguez-Remírez, Inés López, Irati Macaya, Elizabeth Guruceaga

Mol Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.
Irati Macaya, Marta Roman, Connor Welch, Rodrigo Entrialgo-Cadierno, Marina Salmon, Maria Rodriguez-Remirez

Nat Commun· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel [Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer.
Ander Puyalto, María Rodríguez-Remírez, Inés López, Fabiola Iribarren, Jon Ander Simón

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer.
Sonia Solanes-Casado, Arancha Cebrián, María Rodríguez-Remírez, Ignacio Mahíllo, Laura García-García

Biomed Pharmacother· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas.
María Rodríguez-Remírez, Laura Del Puerto-Nevado, María Jesús Fernández-Aceñero, Marlid Cruz-Ramos, Laura García-García

Neuroendocrinology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study.
María Rodríguez-Remírez, Laura Del Puerto-Nevado, María Jesús Fernández Aceñero, Hakimeh Ebrahimi-Nik, Marlid Cruz-Ramos

Neuroendocrinology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of -mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8 T Cells.
Iosune Baraibar, Marta Roman, María Rodríguez-Remírez, Inés López, Anna Vilalta

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.
Marlid Cruz-Ramos, Laura Del Puerto-Nevado, Binbin Zheng, Rafael López-Bajo, Arancha Cebrian

J Geriatr Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UNR/ Expression Is Critical to Maintain Invasive Phenotype of Colorectal Cancer through Regulation of c-MYC and Epithelial-to-Mesenchymal Transition.
Javier Martinez-Useros, Nuria Garcia-Carbonero, Weiyao Li, Maria J Fernandez-Aceñero, Ion Cristobal, Maria Rodriguez-Remirez

J Clin Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
Javier Martinez-Useros, Tihomir Georgiev-Hristov, María Jesús Fernández-Aceñero, Aurea Borrero-Palacios, Alberto Indacochea

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib.
Arancha Cebrián, Teresa Gómez Del Pulgar, María José Méndez-Vidal, María Luisa Gonzálvez, Nuria Lainez

Sci Rep· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Arancha Cebrián, Teresa Gómez Del Pulgar, Maria Jesús Fernández-Aceñero, Aurea Borrero-Palacios, Laura Del Puerto-Nevado

Pathol Res Pract· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer.
Teresa Gómez Del Pulgar, Arancha Cebrián, Maria Jesús Fernández-Aceñero, Aurea Borrero-Palacios, Laura Del Puerto-Nevado

J Cell Mol Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer.
Oscar Aguilera, María Muñoz-Sagastibelza, Blanca Torrejón, Aurea Borrero-Palacios, Laura Del Puerto-Nevado, María Rodriguez-Remirez

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study.
Laura Del Puerto-Nevado, Juan Pablo Marin-Arango, Maria Jesus Fernandez-Aceñero, David Arroyo-Manzano, Javier Martinez-Useros, Maria Rodriguez-Remirez

BMC Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
Javier Martinez-Useros, Maria Rodriguez-Remirez, Aurea Borrero-Palacios, Irene Moreno, Arancha Cebrian

BMC Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis